BIOELECTRON TECHNOLOGY CORPORATION
13Patents
13Active
13Granted
47Portfolio score
Filing activity: Oct 13, 2009 → Jul 19, 2018 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10105325B2 | Treatment of pervasive developmental disorders with redox-active therapeutics | Chemistry; Metallurgy | 4 | Active |
| US9629815B2 | Benzoquinone derivatives for treating oxidative stress disorders | Chemistry; Metallurgy | 3 | Active |
| US9932286B2 | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers | Chemistry; Metallurgy | 3 | Active |
| US10251847B2 | Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide | Chemistry; Metallurgy | 3 | Active |
| US10189830B2 | Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders | Chemistry; Metallurgy | 3 | Active |
| US10071978B2 | Process for the production of alpha-tocotrienol and derivatives | Chemistry; Metallurgy | 3 | Active |
| US10039722B2 | Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells | Human Necessities | 0 | Active |
| US9670170B2 | Resorufin derivatives for treatment of oxidative stress disorders | Chemistry; Metallurgy | 0 | Active |
| US10202325B2 | Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols | Chemistry; Metallurgy | 0 | Active |
| US10029971B2 | Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols | Chemistry; Metallurgy | 0 | Active |
| US10167251B2 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Chemistry; Metallurgy | 0 | Active |
| US9868711B2 | Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders | Chemistry; Metallurgy | 0 | Active |
| US10195161B2 | Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.